Pricing

SOLEL PARTNERS LP

0 followers ยท
BOSTON MA Investment Advisor Hedge Fund
13F Summary

Subscription Required

Equal-WT
WhaleScore 2.0 ?

85

S&P 500
WhaleScore ?

Subscription Required

Equal-WT
WhaleScore 1.0 ?

Solel Partners is based out of Boston. Solel Partners is a hedge fund with 3 clients and discretionary assets under management (AUM) of $1,459,251,688 (Form ADV from 2024-03-25). Their last reported 13F filing for Q3 2024 included $509,650,509 in managed 13F securities and a top 10 holdings concentration of 82.72%. Solel Partners's largest holding is CVS Health Corp with shares held of 1,128,900. Whalewisdom has at least 20 13F filings, and 8 13G filings
Business Description
Solel Partners LP, a Delaware limited partnership, provides investment advisory services to private investment funds. These funds are not registered as investment companies under the Investment Company Act of 1940, and their securities are not registered under the Securities Act of 1933. Solel Capital Partners GP, LLC, a limited liability company formed in Delaware, serves as the general partner for some of these funds. Both Solel and the General Partner were established in 2018 and 2019, respectively, and are based in Boston, Massachusetts. The Managing Partners, Craig Peskin and Peter Fleiss, are responsible for setting the overall investment strategy, determining the size of positions, and managing risk for the portfolios of the funds they manage.
Investment Strategy
Solel's investment strategies are based on identifying undervalued securities and taking long positions, while also identifying overvalued securities and taking short positions. The success of this strategy relies on Solel's ability to accurately predict market movements and capitalize on opportunities arising from corporate developments, macro or geopolitical concerns, and event-driven situations. Solel invests globally across asset classes, with a focus on industries they know well, including consumer and retail, financials, business services, real estate, and certain areas of technology and healthcare. They seek to capitalize on their deep industry knowledge and long-term orientation to take advantage of market dislocations. Solel may also invest in shorter-term, event-driven situations where they believe a security is trading at a discount and a future catalyst will close the gap.
Owners
  • PESKIN, CRAIG, DAVID - LIMITED PARTNER
  • STONE, WILLIAM, CRONIN - CFO/CCO/LIMITED PARTNER
  • FLEISS, PETER, ROBERT OWEN - LIMITED PARTNER
  • SOLEL PARTNERS LLC - GENERAL PARTNER
  • Click on the Ownership/Private Fund Data tab for more details.
Known Email Addresses
(Subscription Required)
Other Contact Information
(Subscription Required)

2024-09-30

Top Buys (13F)

2024-09-30

Top Sells (13F)

Name % Change
HUM Humana, Inc 12.16%
FNF Fidelity National Fi 6.35%
ZUO Zuora Inc 2.82%
HDB HDFC Bank Ltd. 2.2%
CXM Sprinklr Inc 0.65%

2024-09-30

13F Holdings Summary

Name $ Change
CVS CVS Health Corp 13.93%
IGT International Game T 11.15%
SYF Synchrony Financial 10.32%
GO Grocery Outlet Holdi 8.4%
CI Cigna Holding Co 7.36%

2024-09-30

13F Activity

Market Value $0.51b, Prior: $0.61b
Inflows (Outflows) as % of Total MV (-9.8624)%
New Purchases 0 stocks
Added To 5 stocks
Sold out of 4 stocks
Reduced holdings in 6 stocks
Top 10 Holdings % 82.72%
Turnover %[1] 18.18%
Turnover Alt %[2] 17.46%
Time Held Top 20 7 quarters
Time Held Top 10 4.7 quarters
Time Held All 8.72 quarters

[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.

[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.

2024-09-30

13F Sector Allocation Over Time

limited to past 4 quarters. Subscribe to see all available data

2024-09-30

Analysis

Top 20 equal-weighted holdings. Performance numbers calculated through 2024-09-30

Portfolio Performance